[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ID16856A - Turunan-turunan indazol yang disubstitusi dan senyawa-senyawa yang berhubungan - Google Patents

Turunan-turunan indazol yang disubstitusi dan senyawa-senyawa yang berhubungan

Info

Publication number
ID16856A
ID16856A IDP971466A ID971466A ID16856A ID 16856 A ID16856 A ID 16856A ID P971466 A IDP971466 A ID P971466A ID 971466 A ID971466 A ID 971466A ID 16856 A ID16856 A ID 16856A
Authority
ID
Indonesia
Prior art keywords
subazed
subditions
connected compounds
compounds
subazed subditions
Prior art date
Application number
IDP971466A
Other languages
English (en)
Indonesian (id)
Inventor
Anthony Marfat
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ID16856A publication Critical patent/ID16856A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/08Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDP971466A 1996-05-03 1997-05-02 Turunan-turunan indazol yang disubstitusi dan senyawa-senyawa yang berhubungan ID16856A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1686196P 1996-05-03 1996-05-03

Publications (1)

Publication Number Publication Date
ID16856A true ID16856A (id) 1997-11-13

Family

ID=21779401

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP971466A ID16856A (id) 1996-05-03 1997-05-02 Turunan-turunan indazol yang disubstitusi dan senyawa-senyawa yang berhubungan

Country Status (42)

Country Link
US (2) US6211222B1 (fr)
EP (1) EP0912521B1 (fr)
JP (1) JP3148254B2 (fr)
KR (1) KR100339935B1 (fr)
CN (2) CN1112359C (fr)
AP (4) AP1147A (fr)
AR (1) AR006906A1 (fr)
AT (1) ATE292626T1 (fr)
AU (1) AU725576B2 (fr)
BG (1) BG64211B1 (fr)
BR (1) BR9709051A (fr)
CA (2) CA2252982C (fr)
CO (1) CO4650038A1 (fr)
CZ (1) CZ292825B6 (fr)
DE (1) DE69732966T2 (fr)
DZ (1) DZ2217A1 (fr)
EA (1) EA002272B1 (fr)
ES (1) ES2238079T3 (fr)
GT (1) GT199700043A (fr)
HK (1) HK1019443A1 (fr)
HN (1) HN1997000046A (fr)
HR (1) HRP970227B1 (fr)
HU (1) HUP9902459A3 (fr)
ID (1) ID16856A (fr)
IL (2) IL126547A (fr)
IS (1) IS4871A (fr)
MA (1) MA24158A1 (fr)
MY (1) MY132499A (fr)
NO (1) NO312959B1 (fr)
NZ (1) NZ332240A (fr)
OA (1) OA10904A (fr)
PE (1) PE64598A1 (fr)
PL (1) PL329836A1 (fr)
SK (1) SK148298A3 (fr)
TN (1) TNSN97070A1 (fr)
TR (1) TR199802202T2 (fr)
TW (1) TW449585B (fr)
UA (1) UA65536C2 (fr)
UY (1) UY24532A1 (fr)
WO (1) WO1997042174A1 (fr)
YU (1) YU16397A (fr)
ZA (1) ZA973804B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6005118A (en) * 1996-05-03 1999-12-21 Caron; Stephane Methods of preparing 4-cyano-4 (substituted indazole) cyclohexane-carboxylic acids useful as PDE4 inhibitors
AP1147A (en) * 1996-05-03 2003-02-25 Pfizer Substituted indazole derivatives and related compounds.
JP4373497B2 (ja) 1996-06-19 2009-11-25 ローン−プーラン・ロレ・リミテツド 置換されたアザビシクロ化合物、ならびにtnfおよびサイクリックampホスホジエステラーゼ産生の阻害剤としてのそれらの使用
ES2172882T3 (es) * 1997-05-08 2002-10-01 Pfizer Prod Inc Procedimientos y productos intermedios para la preparacion de derivados indazol sustituidos.
SK6262000A3 (en) * 1997-11-04 2002-03-05 Pfizer Prod Inc Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors
JP2001521926A (ja) * 1997-11-04 2001-11-13 ファイザー・プロダクツ・インク 治療上活性の化合物におけるカテコールのインダゾール生物学的等価物置換
IL126745A (en) * 1997-11-04 2003-09-17 Pfizer Prod Inc Methods of preparing 4-cyano-4- (substituted indazole) cyclohexanecarboxylic acids useful as pde4 inhibitors
IL132407A0 (en) * 1998-10-21 2001-03-19 Pfizer Prod Inc Method for treating congestive heart failure
JP2000198734A (ja) * 1998-12-30 2000-07-18 Pfizer Inc 胃運動性減弱および関連疾患の治療のための運動性増強薬
US6362213B1 (en) 1999-12-23 2002-03-26 Icos Corporation Cyclic AMP-specific phosphodiesterase inhibitors
CA2395196C (fr) * 1999-12-23 2006-02-21 Icos Corporation Inhibiteurs de phosphodiesterase specifique d'amp cyclique
US7211594B2 (en) * 2000-07-31 2007-05-01 Signal Pharmaceuticals, Llc Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith
US6897231B2 (en) * 2000-07-31 2005-05-24 Signal Pharmaceuticals, Inc. Indazole derivatives as JNK inhibitors and compositions and methods related thereto
US6953774B2 (en) 2000-08-11 2005-10-11 Applied Research Systems Ars Holding N.V. Methods of inducing ovulation
CA2469939C (fr) 2001-12-14 2012-06-19 Applied Research Systems Ars Holding N.V. Procede permettant d'induire l'ovulation au moyen d'un modulateur du taux de camp non polypeptidique
US20040034084A1 (en) * 2002-05-24 2004-02-19 Celgene Corporation Methods for using JNK inhibitors for treating or preventing disease-related wasting
US7196082B2 (en) * 2002-11-08 2007-03-27 Merck & Co. Inc. Ophthalmic compositions for treating ocular hypertension
US20050019366A1 (en) * 2002-12-31 2005-01-27 Zeldis Jerome B. Drug-coated stents and methods of use therefor
DE10318610A1 (de) 2003-04-24 2004-11-11 Elbion Ag 7-Azaindole und deren Verwendung als Therapeutika
US7601847B2 (en) 2004-10-26 2009-10-13 Wyeth Preparation and purification of 4-(indazol-3-yl)phenols
US20070004777A1 (en) * 2005-03-23 2007-01-04 Bhagwat Shripad S Methods for treating or preventing acute myelogenous leukemia
EP2258358A3 (fr) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenèse avec un inhibiteur de l'acetylcholinestérase
US7678363B2 (en) 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
WO2007047978A2 (fr) 2005-10-21 2007-04-26 Braincells, Inc. Modulation de la neurogenese par inhibition de la pde
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
RU2449808C2 (ru) * 2006-04-21 2012-05-10 Сентокор, Инк. Антагонисты cxcl13 и их применение для лечения воспалительных заболеваний
CA2651813A1 (fr) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenese par modulation de l'angiotensine
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (fr) 2009-02-25 2010-09-02 Braincells, Inc. Modulation de neurogenèse à l'aide de combinaisons de d-cyclosérine
WO2013106547A1 (fr) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Composés promoteurs de réplication des cellules bêta et leurs procédés d'utilisation
CN111918652A (zh) 2017-11-06 2020-11-10 拉普特医疗公司 用于治疗eb病毒阳性的癌症的趋化因子受体调节剂

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3994890A (en) * 1974-01-31 1976-11-30 Chugai Seiyaku Kabushiki Kaisha 1-Aminoalkyl, 3-phenyl indazoles
JPS5654437A (en) * 1979-10-09 1981-05-14 Konishiroku Photo Ind Co Ltd Direct positive image forming method
GB8707051D0 (en) * 1986-04-15 1987-04-29 Ici America Inc Heterocyclic carboxamides
JP2525286B2 (ja) * 1990-11-26 1996-08-14 日本原子力研究所 超耐熱性炭化ケイ素繊維の製造方法
TW223004B (fr) * 1991-11-25 1994-05-01 Sumitomo Chemical Co
EP0630367B1 (fr) * 1992-03-09 2000-07-05 Zeneca Limited Nouveaux arylindazoles et leur utilisation comme herbicides
US5444038A (en) * 1992-03-09 1995-08-22 Zeneca Limited Arylindazoles and their use as herbicides
EP0633776B1 (fr) * 1992-04-02 2001-05-09 Smithkline Beecham Corporation Composes destines a traiter les maladies allergiques et inflammatoires
US5554620A (en) * 1993-09-14 1996-09-10 Sterling Winthrop Inc. Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts and compositions and methods of use thereof
US5440038A (en) * 1993-12-07 1995-08-08 Miles Inc. Process for the purification of substituted 4-amino-1,2,4-triazine-5-ones
CZ120097A3 (cs) * 1994-10-20 1998-01-14 Pfizer Inc. Bicyklické tetrahydropyrazolopyridiny a farmaceutické prostředky na jejich bázi
KR970707243A (ko) * 1994-10-21 1997-12-01 헤이만, 로버트 엘 금속제품에 대한 내식성 완충 시스템(corrosion resistant buffer system for metal products)
AP1147A (en) * 1996-05-03 2003-02-25 Pfizer Substituted indazole derivatives and related compounds.
ES2172882T3 (es) * 1997-05-08 2002-10-01 Pfizer Prod Inc Procedimientos y productos intermedios para la preparacion de derivados indazol sustituidos.

Also Published As

Publication number Publication date
CN1422849A (zh) 2003-06-11
PE64598A1 (es) 1998-10-26
AP1146A (en) 2003-02-25
EA002272B1 (ru) 2002-02-28
CA2252982C (fr) 2002-10-08
AP2001002294A0 (en) 2001-12-31
AP9700975A0 (en) 1997-07-31
KR20000010751A (ko) 2000-02-25
UA65536C2 (en) 2004-04-15
CZ349298A3 (cs) 1999-09-15
HN1997000046A (es) 1997-06-26
HUP9902459A3 (en) 2001-10-29
TR199802202T2 (xx) 1999-02-22
OA10904A (en) 2001-10-11
AP1147A (en) 2003-02-25
EP0912521A1 (fr) 1999-05-06
ES2238079T3 (es) 2005-08-16
GT199700043A (es) 1998-10-02
US6127398A (en) 2000-10-03
AU725576B2 (en) 2000-10-12
CZ292825B6 (cs) 2003-12-17
NZ332240A (en) 2000-07-28
NO312959B1 (no) 2002-07-22
MY132499A (en) 2007-10-31
IS4871A (is) 1998-10-16
DE69732966D1 (de) 2005-05-12
SK148298A3 (en) 2000-02-14
IL152083A0 (en) 2003-05-29
AU1937397A (en) 1997-11-26
JP3148254B2 (ja) 2001-03-19
CN1217714A (zh) 1999-05-26
CN1112359C (zh) 2003-06-25
NO985095L (no) 1998-12-29
ATE292626T1 (de) 2005-04-15
EA199800882A1 (ru) 1999-06-24
UY24532A1 (es) 2000-09-29
WO1997042174A1 (fr) 1997-11-13
HK1019443A1 (en) 2000-02-11
AP2001002304A0 (en) 2001-12-31
IL126547A0 (en) 1999-08-17
BG64211B1 (bg) 2004-05-31
DZ2217A1 (fr) 2002-12-03
BR9709051A (pt) 1999-08-03
KR100339935B1 (ko) 2002-07-18
CA2389918A1 (fr) 1997-11-13
AP0102304A0 (en) 1997-11-03
CO4650038A1 (es) 1998-09-03
TW449585B (en) 2001-08-11
US6211222B1 (en) 2001-04-03
HRP970227A2 (en) 2000-12-31
HUP9902459A2 (hu) 1999-11-29
CA2252982A1 (fr) 1997-11-13
AR006906A1 (es) 1999-09-29
BG102946A (en) 1999-11-30
TNSN97070A1 (fr) 2005-03-15
JPH11508284A (ja) 1999-07-21
ZA973804B (en) 1998-11-02
HRP970227B1 (en) 2002-06-30
MA24158A1 (fr) 1997-12-31
IL126547A (en) 2003-03-12
DE69732966T2 (de) 2005-09-08
YU16397A (sh) 1999-12-27
NO985095D0 (no) 1998-11-02
EP0912521B1 (fr) 2005-04-06
PL329836A1 (en) 1999-04-12

Similar Documents

Publication Publication Date Title
ID16856A (id) Turunan-turunan indazol yang disubstitusi dan senyawa-senyawa yang berhubungan
ID22426A (id) Ketobenzamida yang baru dan penggunaannya
ID24839A (id) Senyawa-senyawa triazol dan penggunaannya
ID19422A (id) Piridina dan bifenil tersubstitusi
NO993068D0 (no) Ny forbindelsesform
ID19833A (id) Aralkil dan aralkilidena heterosiklik laktam dan imida
ID28110A (id) Surfaktan alkilbenzenasulfonat yang disempurnakan
ID25651A (id) Senyawa-senyawa bisiklo [2.2.1] heptana dan senyawa-senyawa yang terkait
EG21153A (en) Use of oil and gasfield chemicals
IS5419A (is) Vatnshreinsunar- og vatnsmiðlunartæki
ID18679A (id) Penggunaan terapi lanjutan
ID16889A (id) Senyawa turunan alkilaminobenzotiazol dan benzoksazol
FI960450A (fi) Lukitusteline
ID18682A (id) Asiltransferase dan plasma yang mengkodekan asiltransferase
ID18456A (id) Produksi-bersama 6-aminokapronitril dan heksametilenadiamina
DE69617446D1 (de) Verriegelungseinheit
ID20134A (id) Proses dan peralatan sintesis urea yang ditingkatkan
ID21770A (id) Plester yang mengandung felbinak
ID16587A (id) Koproduksi 6-aminokapronitril dan heksametilendiamin
ID19147A (id) Ksilanase dan pemakaiannya
ID18459A (id) Produksi-bersama 6-aminokapronitril dan heksametilenadiamina
EP0964691A4 (fr) Utilisation de conantokines
ID18913A (id) Turunan turunan tienopiridin dan penggunaannya
ID21419A (id) Saklar dan peralatan saklar yang menggunakan saklar
ID17395A (id) Aluminosilikat berbentuk beraturan dan penggunaannya